Insights into the pathogenicity of Penicillium marneffei

Future Microbiology

Volumn 3, Issue 1, 2008, Pages 43-55

  Cooper Jr , Chester R ^a   Vanittanakom, Nongnuch ^b  

^a YOUNGSTOWN STATE UNIVERSITY   (United States)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Dimorphism; Genomics; Pathogenesis; Penicilliosis; Penicillium marneffei; Phase transition; Proteomics; Signal transduction; Transcription factors; Virulence factors

Indexed keywords

AMPHOTERICIN B; CATALASE; ITRACONAZOLE; PEROXIDASE; SUPEROXIDE DISMUTASE; VIRULENCE FACTOR; FUNGAL PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASEXUAL REPRODUCTION; FUNGAL GENETICS; FUNGAL METABOLISM; FUNGAL MORPHOLOGY; FUNGAL VIRULENCE; FUNGUS GROWTH; GENE EXPRESSION PROFILING; GENOMICS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; MOLECULAR BIOLOGY; MYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PENICILLIUM MARNEFFEI; PHAGOCYTOSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SOUTHEAST ASIA; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PENICILLIUM; VIRULENCE;

EUKARYOTA; FUNGI; PENICILLIUM MARNEFFEI; SCHIZOSACCHAROMYCETACEAE;

ANIMALS; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MYCOSES; PENICILLIUM; PROTEOMICS; VIRULENCE;

EID: 39049143884     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.3.1.43     Document Type: Review

References (88)

1. Dighton J, White JF, Oudemans P: The Fungal Community: Its Organization and Role in the Ecosystem. Taylor & Francis, Boca Raton, FL, USA (2005).
2. Cooper CR Jr, Haycocks NG: Penicillium marneffei. an insurgent species among the penicillia. J. Eukaryot. Microbiol. 47(1), 24-28 (2000).
3. Lyratsopulos G, Ellis M, Nerringer R, Denning DW: Invasive infection due to Penicillium species other than P. marneffei. J. Infect. 45(3), 184-195 (2002).
4. Odds FC, Rinaldi MG: Nomenclature of fungal diseases. Curr. Top. Med. Mycol. 6, 33-46 (1995).
5. Odds FC, Arai T, Disalvo AF et al.: Nomenclature of fungal diseases: a report and recommendations from a subcommittee of the International Society for Human and Animal Mycology (ISHAM). J. Med. Vet. Mycol. 30(1), 1-10 (1992).
6. Drouhet E: Penicilliosis due to Penicillium marneffei. a new emerging systemic mycosis in AIDS patients travelling or living in Southeast Asia. Review of 44 cases reported in HIV infected patients during the last 5 years compared to 44 cases of non AIDS patients reported over 20 years. J. Mycol. Med. 4, 195-224 (1993).
7. Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T: Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin. Microbiol. Rev. 19(1), 95-110 (2006).
8. Viviani MA, Vanittanakom N: Penicilliosis. In: Medical Mycology. Merz WG, Hay RJ (Eds). Hodder Arnold, London, UK, 560-575 (2005).
9. Capponi M, Sureau P, Segretain G: Pénicillose de Rhizomys sinensis. Bull. Soc. Pathol. Exotique 49(3), 418-421 (1956).
10. Segretain G: Penicillium marneffei N. Sp., agent d'une mycose due système rétículoenothélial. Mycopathol. Mycol. Appl. 11(4), 327-353 (1959).
11. Segretain G: Description d'une nouvelle espéce de Penicillium. Penicillium marneffei N. Sp. Bull. Soc. Mycol. Fr. 75, 412-416 (1959).
12. DiSalvo AF, Fickling AM, Ajello L: Infection caused by Penicillium marneffei. description of first natural infection in man. Am. J. Clin, Pathol. 60(2), 259-263 (1973).
13. Cooper CR Jr, McGinnis MR: Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen. Arch. Pathol. Lab. Med. 121(8), 798-804 (1997).
14. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Nelson KE: Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir? J. Infect. Dis. 173(6), 1490-1493 (1996).
15. Restrepo A, Baumgardner DJ, Bagagli E et al.: Clues to the presence of pathogenic fungi in certain environments. Med. Mycol. 38(Suppl. 1), 67-77 (2000).
16. Cooper CR Jr: From bamboo rats to humans: the odyssey of Penicillium marnaffei. ASM News 64(7), 390-397 (1998).
17. Fisher MC, Hanage WP, de Hong S et al.: Low effective dispersal of asexual genotypes in heterogeneous landscapes by the endemic pathogen Penicillium marnaffei. PLoS Pathog. 1(2), e20 (2005).
18. Supparatpinyo, K, Nelson KE, Merz WG et al.: Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob. Agentr Chemother. 37(11), 2407-2411 (1993).
19. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE: Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 26(5), 1107-1110 (1998).
20. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE: A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin. Infect. Dis. 34(2), 277-284 (2002).
21. Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T: A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 339(24), 1739-1743 (1998).
22. Supparatpinyo K, Schlamm HT: Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. Am. J. Trop. Med. Hyg. 77 (2), 350-353 (2007).
23. Dannaoui E, Garcia-Hermoso D, Naccache JM et al.: Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus. J. Med. Microbiol. 55(10), 1457-1459 (2006).
24. Howard SJ, Webster I, Moore CB et al.: Multi-azole resistance in Aspergillus fumigatus. Int. J. Antimicrob. Agents 28 (5), 450-453 (2006).
25. Szaniszlo PJ: An introduction to dimorphism among zoopathogenic fungi. In: Fungal Dimorphism: With Emphasis on Fungi Pathogenic for Humans. Szaniszlo PJ (Ed.). Plenum, NY, USA, 3-13 (1985).
26. Klein BS, Tebbets B: Dimorphism and virulence in fungi. Curr. Opin. Microbiol. 10(4), 314-319 (2007).
27. Nemecek JC, Wuthrich M, Klein BS: Global control of dimorphism and virulence in fungi. Science 312(5773), 583-588 (2006).
28. Pracharktam R, Sriurairatna S, Jayanetra P: Morphological variation in pathogenic strains of Penicillium marneffei. J. Med. Assoc. Thai. 75(Suppl. 1), 172-179 (1992).
29. Chan YF, Chow TC: Ultrastructural observations on Penicillium marneffei in natural human infection. Ultrastruct. Pathol. 14(5), 439-452 (1990).
30. Garrison RG, Boyd KS: Dimorphism of Penicillium marneffei as observed by electron microscopy. Can. J. Microbiol. 19 (10), 1305-1309 (1973).
31. Andrianopoulos A, Zuber S: Signaling pathways in the dimorphic human fungal pathogen Penicillium marneffei. In: Molecular Principles of Fungal Pathogenis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP (Eds). ASM Press, Washington, DC, USA 441-454 (2006).
32. Andrianopoulos A: Control of morphogenesis in the human fungal pathogen Penicillium marneffei. Int. J. Med. Microbiol. 292(5-6), 331-347 (2002).
33. Woo PC, Chong KT, Tse H et al.: Genomic and experimental evidence for a potential sexual cycle in the pathogenic thermal dimorphic fungus Penicillium marneffei. FEBS Lett. 580(14), 3409-3416 (2006).
34. Borneman AR, Hynes MJ, Andrianopoulos A: An STE12homolog from the asexual, dimorphic fungus Penicillium marneffei complements the defect in sexual development of an Aspergillus nidulan steA mutant. Genetics 157(3), 1003-1014 (2001).
35. Borneman AR, Hynes MJ, Andrianopoulos A: The abaA homologue of Penicillium marneffei participates in two developmental programmes: conidiation and dimorphic growth. Mol. Microbiol. 38(5), 1034-1047 (2000).
36. Borneman AR, Hynes MJ, Andrianopoulos A: A basic helix-loop-helix protein with similarity to the fungal morphological regulators, Phd1p, Efg1p and StuA, controls conidiation but not dimorphic growth in Penicillium marneffei. Mol. Microbiol. 44 (3), 621-631 (2002).
37. Todd RB, Greenhalgh JR, Hynes MJ, Andrianopoulos A: TupA, the Penicillium marneffei Tup1p homologue, represses both yeast and spore development. Mol. Microbiol. 48(1), 85-94 (2003).
38. Pongsunk S, Andrianopoulos A, Chaiyaroj SC: Conditional lethal disruption of TATA-binding protein gene in Penicillium marneffei. Fungal Genet. Biol. 42(11), 893-903 (2005).
39. Kruppa M, Calderone R: Two-component signal transduction in human fungal pathogens. FEMS Yeast Res. 6(2), 149-159 (2006).
40. Mendes-Giannini MJ, Scares CP da Silva JL, Andreotti PF: Interaction of pathogenic fungi with host cells: molecular and cellular approaches. FEMS Immunol. Med. Microbiol. 45(3), 383-394 (2005).
41. Li L, Wright SJ, Krystofova S, Park G, Borkovich KA: Heterotrimeric G protein signaling in filamentous fungi. Annu. Rev. Microbiol. 61, 423-452 (2007).
42. Zuber S, Hynes MJ, Andrianopoulos A: G-protein signaling mediates asexual development at 25°C but has no effect on yeast-tike growth at 37°C in the dimorphic fungus Penillium mameffei. Eukaryot. Cell 1(3), 440-447 (2002).
43. Zuber S, Hynes MJ, Andrianopoulos A: The G-protein a-subunit GasC plays a major role in germination in the dimorphic fungus Penicillium marneffei. Genitics 164(2), 487-499 (2003).
44. Boyce KJ, Hynes MJ, Andrianopoulos A: The CDC42homolog of the dimorphic fungus Penicillium marneffei is required for correct cell polarization during growth but not development. J. Bacteriol. 183 (11), 3447-3457 (2001).
45. Boyce KJ, Hynes MJ, Andrianopoulos A: The Ras and Rho GTPases genetically interact to co-ordinately regulate cell polarity during development in Penicillium marneffei. Mol. Microbiol. 55(5), 1487-1501 (2005).
46. Boyce KJ, Hynes MJ, Andrianopoulos A: Control of morphogenesis and actin localization by the Penicillium marneffei RAC homolog. J. Cell Sci. 116(Pt 7), 1249-1260 (2003).
47. Munoz-Elias EJ, McKinney JD: Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11 (6), 638-644 (2005).
48. Lorenz MC, Fink GR: Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot. Cell 1 (5), 657-662 (2002).
49. Wall DM, Duffy PS, Dupont C, Prescott JF, Meijer WG: Isocitrate lyase activity is required for virulence of the intracellular pathogen Rhodococcus equi. Infect. Immun. 73(10), 6736-6741 (2005).
50. Barelle CJ, Priest CL, Maccallum DM, Gow NA, Odds FC, Brown AJ: Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cell Microbiol. 8(6), 961-971 (2006).
51. Canovas D, Andrianopoulos A: Developmental regulation of the glyoxylate cycle in the human pathogen Penicillium marneffei. Mol. Microbiol. 62 (6), 1725-1738 (2006).
52. Rude TH, Toffaletti DL, Cox GM, Perfect JR: Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neofarmans. Infect. Immun. 70(10), 5684-5694 (2002).
53. Liu H, Xi L, Zhang J et al.: Identifying differentially expressed genes in the dimorphic fungus Penicillium marneffei by suppression subtractive hybridization. FEMS Microbiol. Lett. 270(1), 97-103 (2007).
54. Kozminski KG, Beven L, Angerman E, Tong AH, Boone C, Park HO: Interaction between a Ras and a Rho GTPase couples selection of a growth site to the development of cell polarity in yeast. Mol. Biol. Cell 14(12), 4958-4970 (2003).
55. Hausauer DL, Gerami-Nejad M, Kistler-Anderson C, Gale CA: Hyphal guidance and invasive growth in Candida albicans require the Ras-like GTPase Rsr1p and its GTPase-activating protein Bud2p. Eukaryot. Cell 4(7), 1273-1286 (2005).
56. Yaar L, Mevarech M, Koltin Y A Candida albicans RAS-related gene (CaRSR1) is involved in budding, cell morphogenesis and hypha development. Microbiology 143 (9). 3033-3044 (1997).
57. Cushion MT: Pneumocystis pneumonia. In: Medical Mycology. Merz WG, Hay RJ (Eds). Hodder Arnold, London, UK 763-805 (2005).
58. Hamilton AJ, Jeavons L, Youngchim, S, Vanittanakom N, Hay RJ: Sialic acid-dependent recognition of laminin by Penicillium marneffei conidia. Infect. Immun. 66(12), 6024-6026 (1998).
59. Xi L, Xu X, Liu W et al.: Differentially expressed proteins of pathogenic Penicillium marneffei in yeast and mycelial phases. J. Med. Microbiol. 56(3), 298-304 (2007).
60. Liu DH, Liu XJ, Tan SS: Analysis or the difference in proteome expression between yeast form and mould form of Penicillium marneffei using SELDI technique. J. South Med. Univ. 27(1), 59-61 (2007).
61. Ikai N, Yanagida M: Cdc48 is required for the stability of Cut1/separase in mitotic anaphase. J. Struct. Biol. 156(1), 50-61 (2006).
62. Fu X, Ng C, Feng D, Liang C: Cdc48p is required for the cell cycle commitment point at Start via degradation of the G1-CDK inhibitor Far1p. J. Cell Biol. 163(1), 21-26 (2003).
63. Mandel MA, Gaigiani JN, Kroken S, Orbach MJ: Coccidioides posadasii contains single chitin synthase genes corresponding to classes I to VII. Fungal Genet. Biol. 43(11), 775-788 (2006).
64. Szaniszlo PJ: Molecular genetic studies of the model dematiaceous pathogen Wangiella dermatitidis. Int. J. Med. Microbiol. 292(5-6), 381-390 (2002).
65. Sazer S: Nuclear envelope: nuclear pore complexity. Curr. Biol. 15(1), R23-R26 (2005).
66. Barbosa MS, Bao SN, Andreotti PF et al.: Glyceraldehyde-3-phosphate dehydrogenase of Paracoccidioides brasiliensis is a cell surface protein involved in fungal adhesion to extracellular matrix proteins and interaction with cells. Infect. Immun. 74(1), 382-389 (2006).
67. Saville SP, Thomas DP, Lopez Ribot JL: A role for Efg1p in Candida albicans interactions with extracellular matrices. FEMS Microbiol. Lett. 256(1), 151-158 (2006).
68. Warwas ML, Watson JN, Bennet AJ, Moore MM: Structure and role of sialic acids on the surface of Aspergillus fumigatus conidiospores. Glycobiology 17(4), 401-410 (2007).
69. Heise T, Dersch P: Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake. Proc. Natl Acad. Sci. USA 103(9), 3375-3380 (2006).
70. Srinoulprasert Y, Kongtawelert P, Chaiyaroj SC: Chondroitin sulfate B and heparin mediate adhesion of Penicillium marneffei conidia to host extracellular matrices. Microb. Pathog. 40(3), 126-132 (2006).
71. Sisto F, Miluzio A, Leopardi O, Mirra M, Boelaert JR, Taramelli D: Differential cytokine pattern in the spleens and livers of BALB/c mice infected with Penicillium marneffei. protective role of γ interferon. Infect. Immun. 71(1), 465-473 (2003).
72. Youngchim S, Vanittanakorn N, Hamilton AJ: Analysis of the enzymatic activity of mycelial and yeast phases of Penicillium marneffei. Med. Mycol. 37(6), 445-450 (1999).
73. Kummasook A, Pongpom P, Vanittanakom N: Cloning, characterization and differential expression of an hsp70 gene from the pathogenic dimorphic fungus, Penicillium marneffei. DNA Seq. 18(5), 385-394 (2007).
74. Pongpom P, Cooper CR Jr, Vanittanakom N: Isolation and characterization of a catalase-peroxidase gene from the pathogenic fungus, Penicillium marneffei. Med. Mycol. 43(5), 403-411 (2005).
75. Thirach S, Cooper CR Jr, Vanittanakom P, Vanittanakom N: The copper, zinc superoxide dismutase gene of Pinicillium marneffei. cloning, characterization, and differential expression during phase transition and macrophage infection. Med. Mycol. 45(5), 409-417 (2007).
76. Picklington DL, Fang FC, Laessig T, Cooper AM, Orme IM, Buchmeier NA: Cu, Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect. Immun. 69(8), 4980-4987 (2001).
77. Martchenko M, Alarco AM, Harcus D, Whiteway M: Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene. Mol. Biol. Cell 15(2), 456-467 (2004).
78. Cox GM, Harrison TS, McDade HC et al.: Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect. Immun. 71(1), 173-180 (2003).
79. Tavares AH, Silva SS, Bernardes VV et al.: Virulence insights from the Paracoccidioides brasiliensis transcriptome. Genet. Mol. Res. 4(2), 372-389 (2005).
80. Ng VH, Cox JS, Sousa AO, MacMicking JD, McKinney JD: Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52(5), 1291-1302 (2004).
81. Shibuya K, Paris S, Ando T, Nakayama H, Hatori T, Latge JP: Catalases of Aspergillus fumigatus and inflammation in aspergillosis. Nippon Ishinkin Gakkai Zasshi 47(4), 249-255 (2006).
82. Bastos KP, Bailao AM, Borges CL et al.: The transcriptome analysis of early morphogenesis in Paracoccidioides brasiliensis mycelium reveals novel and induced genes potentially associated to the dimorphic process. BMC Microbiol. 7, 29 (2007).
83. Burnie JP, Carter TL, Hodgetts SJ, Matthews RC: Fungal heat-shock proteins in human disease. FEMS Microbiol. Res. 30(1), 53-88 (2006).
84. Bhardwaj S, Shukla A, Mukherjee S et al.: Putative structure and characteristics of a red water-soluble pigment secreted by Penicillium marneffei. Med. Mycol. 45(5), 419-427 (2007).
85. Nosanchuk JD, Casadevall A: Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob. Agents Chemother. 50(11), 3519-3528 (2006).
86. Youngchim S, Hay RJ, Hamilton AJ: Melanization of Penicillium marneffei in vitro and in vivo. Microbiology 151(1), 291-299 (2005).
87. Kudeken N, Kawakami K, Kusano N, Saito A: Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J. Med. Vet. Mycol. 34(6), 371-378 (1996).
88. + T cell-mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei. Clin. Exper. Immunol. 107(3), 468-473 (1997).